Bloomberg · Sep 2025
Thyme Care raised $97M in Series D financing at a reported $1B valuation, according to Bloomberg. The company’s own announcement listed strategic participation from Morgan Health, Humana, Texas Oncology, and Memorial Hermann.
Public company, workplace, funding, and market signals
Updated Aug 16, 2026
Thyme Care is a Nashville-based value-based oncology-care company that partners with health plans, employers, risk-bearing providers, and oncology practices to improve cancer outcomes, patient experience, and affordability. Its model combines virtual oncology navigation, clinical care teams, provider enablement, analytics, pharmacy interventions, palliative care, and survivorship support.
Primary product
Technology-enabled value-based cancer-care platform, including 24/7 virtual oncology navigation, care management, provider enablement through Thyme Care Oncology Partners, analytics, pharmacy-cost interventions, palliative care, and survivorship programs.
Founded
2020
Headquarters
Nashville, Tennessee, United States
Team size
301-500
Work style
Hybrid
Industry
Hospitals and Health Care
Sub-industry
Value-based oncology care, cancer navigation, digital health, healthcare services
Offices
Business model
Stage
Series D / late-stage venture-backed private company
Total raised
$275M
Latest round
Series D · Sep 2025
Latest amount
$97M
Sep 2025 · Strategic investor group including Morgan Health, Humana, Texas Oncology, and Memorial Hermann Health System
Jul 2024 · Concord Health Partners; Banc of California provided $40M debt financing
Aug 2023 · Foresite Capital and Town Hall Ventures
May 2021
Leadership
Chief Executive Officer
Co-Founder and Executive Chairman
Co-Founder, President, and Chief Medical Officer
Founding Team Member and Senior Vice President, Operations
Senior Vice President, People
Senior Vice President, Product
Head of Enterprise Strategy and Solutions
Head of Communications
General Manager, Clinical Trials
Lalan Wilfong, MD
Senior Vice President, Value-Based Care
Public recruiting materials emphasize a mission-driven, patient-centered, collaborative culture focused on making cancer care more connected, compassionate, and human. The company combines clinical expertise with technology, data, and virtual care teams, and appears to support distributed U.S. hiring alongside a Nashville hybrid hub.
Work style
Hybrid
Compensation
Public job-posting signals include $85,000 base salary for a Team Lead, Enrollment Education & Enablement role and $140,250-$165,000 base salary plus bonus eligibility for a Senior Manager, CRM & Lifecycle Marketing role. Equity and bonus eligibility are cited for some positions; comprehensive compensation data is unavailable.
Benefits
Pricing
Not publicly disclosed; appears to be enterprise contracting with health plans, employers, providers, and risk-bearing organizations, generally tied to value-based or shared-savings arrangements rather than consumer subscription pricing.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approximately $1M-$10M annually; Exa estimates approximately $5M in annual revenue. This is an external estimate, not company-reported revenue.
Estimated monthly visits
28.5K
Traffic estimate as of Jun 2026
Bloomberg · Sep 2025
Thyme Care raised $97M in Series D financing at a reported $1B valuation, according to Bloomberg. The company’s own announcement listed strategic participation from Morgan Health, Humana, Texas Oncology, and Memorial Hermann.
Thyme Care · Sep 2025
Thyme Care announced its $97M Series D, bringing stated total capital raised to $275M, and described its national oncology infrastructure, strategic investors, oncology network, AI, care teams, palliative care, and survivorship capabilities.
The American Journal of Managed Care · Apr 2025
AON reported nearly $6M in Medicare savings during the first Enhancing Oncology Model performance period, citing pharmacy interventions, comprehensive navigation, real-time performance data, and virtual palliative-care support.
Humana · Feb 2025
Humana announced a value-based cancer-care agreement covering eligible Medicare Advantage members in Michigan, New York, Illinois, Indiana, Tennessee, Pennsylvania, and New Jersey, including 24/7 virtual navigation and clinical support.
Thyme Care · Dec 2024
Thyme Care announced partnerships with EmblemHealth, Oak Street Health, and Vytalize Health, more than 850 oncology partners, projected reach of over 40,000 people with cancer in 2025, and projected pharmacy savings with AON.
44 jobs at Thyme Care